Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism
The paper evaluates the impact of hormone replacement therapy (HRT) with androgens on cardiac metabolic indicators in men with high cardiovascular risk (CVR) and androgen deficiency state. An open-label randomized clinical trial enrolled 52 men aged 30–64 years with high CVR and detected androgen-de...
Main Authors: | M. N. Mamedov, G. G. Sharvadze, A. A. Yevdokimova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-12-01
|
Series: | Andrologiâ i Genitalʹnaâ Hirurgiâ |
Subjects: | |
Online Access: | https://agx.abvpress.ru/jour/article/view/84 |
Similar Items
-
Impact of hormone replacement therapy on cardiac metabolic indicators in men with high cardiovascular risk and hypogonadism
by: M. N. Mamedov, et al.
Published: (2014-12-01) -
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
by: Kushner Harvey, et al.
Published: (2011-11-01) -
Complex application of certain micronatrients in men with androgen deficiency and pathosprimes
by: A. S. Minukhin, et al.
Published: (2018-02-01) -
The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
by: Galina A. Melnichenko, et al.
Published: (2019-06-01) -
Possibility of the use of herbal medicines in steroidogenesis in hypogonadal men
by: A. B. Bat’ko, et al.
Published: (2016-07-01)